Recently it was demonstrated that an increased MPO level in patient’s blood serves as a risk marker for atherosclerosis and coronary artery disease. MPO was also shown to give an early risk warning of myocardial infarction, as well as the risk of other major adverse cardiac events in patients with chest pain in the ensuing 30-day and 6-month periods